Study Evaluating Effectiveness and Safety of Zimberelimab and Domvanalimab in Lung Cancer

Clinical trial NCT04736173 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04736173
Sponsor: Arcus Biosciences, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer Nonsquamous Non Small Cell Lung Cancer Squamous Non Small Cell Lung Cancer Lung Cancer

Start date: 2021-02-08
Primary completion: 2027-05-01
Enrollment: 169

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.